Transcode Therapeutics RNAZ
NASDAQ RNAZ
$1.53 -0.12 (-7.26%)
As of: Oct 1, 2026 · 3:59 PM EDT

Transcode Therapeutics (RNAZ) Liabilities and Shareholders Equity (2020 - 2026)

Updated

Transcode Therapeutics' Liabilities and Shareholders Equity came in at $151.01 million for Q2 2026, compared with $8.27 million a year earlier and down 3.9% from the prior quarter.

Analysis

Transcode Therapeutics (RNAZ) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

At the end of FY2025, Transcode Therapeutics' Liabilities and Shareholders Equity was $162.4 million.

  • Liabilities and Shareholders Equity carries a five-year compound annual growth rate of 173.8% (FY2020 to FY2025).
  • Going back by year, Liabilities and Shareholders Equity was $7.29 million in FY2024 (+41.1%), $5.17 million in FY2023 (-31.9%), $7.59 million in FY2022 (-66.9%) and $22.94 million in FY2021.
  • The five-year range for quarterly Liabilities and Shareholders Equity is $3.94 million (Q3 2024) to $162.4 million (Q4 2025).
  • Year-over-year, Liabilities and Shareholders Equity increased in four of the last five quarters, with growth averaging 32.9%.
  • The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in Q2 2022 (growth of 829.9%), and the weakest in Q1 2023 (a decline of 70.3%).
  • Business Quant data shows RNAZ's Liabilities and Shareholders Equity at $157.16 million (Q1 2026), $162.4 million (Q4 2025) and $5.23 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Transcode Therapeutics 1.70 Mn 1.70 Mn - 151.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 151.01 Mn
Mar 31, 2026 157.16 Mn
Dec 31, 2025 162.40 Mn
Sep 30, 2025 5.23 Mn
Jun 30, 2025 8.27 Mn
Mar 31, 2025 13.19 Mn
Dec 31, 2024 7.29 Mn
Sep 30, 2024 3.94 Mn
Jun 30, 2024 4.82 Mn
Mar 31, 2024 7.29 Mn
Dec 31, 2023 5.17 Mn
Sep 30, 2023 10.23 Mn
Jun 30, 2023 5.88 Mn
Mar 31, 2023 5.59 Mn
Dec 31, 2022 7.59 Mn
Sep 30, 2022 12.02 Mn
Jun 30, 2022 14.16 Mn
Mar 31, 2022 18.85 Mn
Dec 31, 2021 22.94 Mn
Sep 30, 2021 25.36 Mn
API Access

Transcode Therapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=RNAZ&period=max&api_key=YOUR_API_KEY